These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 34474270)

  • 1. Definitive tumor directed therapy confers a survival advantage for metachronous oligometastatic HPV-associated oropharyngeal cancer following trans-oral robotic surgery.
    Wright CM; Lee DY; Shimunov D; Carmona R; Barsky AR; Sun L; Cohen RB; Bauml JM; Brody RM; Basu D; Rassekh CH; Chalian AA; Newman JG; Rajasekaran K; Weinstein GS; Lukens JN; Lin A; Swisher-McClure S
    Oral Oncol; 2021 Oct; 121():105509. PubMed ID: 34474270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluating the impact of smoking on disease-specific survival outcomes in patients with human papillomavirus-associated oropharyngeal cancer treated with transoral robotic surgery.
    Roden DF; Hobelmann K; Vimawala S; Richa T; Fundakowski CE; Goldman R; Luginbuhl A; Curry JM; Cognetti DM
    Cancer; 2020 Jan; 126(9):1873-1887. PubMed ID: 32032441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identifying an oligometastatic phenotype in HPV-associated oropharyngeal squamous cell cancer: Implications for clinical trial design.
    Fleming CW; Ward MC; Woody NM; Joshi NP; Greskovich JF; Rybicki L; Xiong D; Contrera K; Chute DJ; Milas ZL; Frenkel CH; Brickman DS; Carrizosa DR; Ku J; Prendes B; Lamarre E; Lorenz RR; Scharpf J; Burkey BB; Schwartzman L; Geiger JL; Adelstein DJ; Koyfman SA
    Oral Oncol; 2021 Jan; 112():105046. PubMed ID: 33129058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of human papillomavirus on patterns of distant metastatic failure in oropharyngeal squamous cell carcinoma treated with chemoradiotherapy.
    Trosman SJ; Koyfman SA; Ward MC; Al-Khudari S; Nwizu T; Greskovich JF; Lamarre ED; Scharpf J; Khan MJ; Lorenz RR; Adelstein DJ; Burkey BB
    JAMA Otolaryngol Head Neck Surg; 2015 May; 141(5):457-62. PubMed ID: 25742025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oligometastatic status as predictor of survival in metastatic human papillomavirus-positive oropharyngeal carcinoma.
    Albergotti WG; Abberbock S; Mathews F; Ferris RL; Johnson JT; Duvvuri U; Kim S
    Head Neck; 2018 Aug; 40(8):1685-1690. PubMed ID: 29756301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of human papillomavirus status on prognosis and local treatment strategies of T1-2N0 oropharyngeal squamous cell cancer.
    Zhou P; Chen DL; Lian CL; Wu SG; Zhang SY
    Front Public Health; 2022; 10():900294. PubMed ID: 35958856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiation therapy dose de-escalation compared to standard dose radiation therapy in definitive treatment of HPV-positive oropharyngeal squamous cell carcinoma.
    Gabani P; Lin AJ; Barnes J; Oppelt P; Adkins DR; Rich JT; Zevallos JP; Daly MD; Gay HA; Thorstad WL
    Radiother Oncol; 2019 May; 134():81-88. PubMed ID: 31005228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surgical salvage improves overall survival for patients with HPV-positive and HPV-negative recurrent locoregional and distant metastatic oropharyngeal cancer.
    Guo T; Qualliotine JR; Ha PK; Califano JA; Kim Y; Saunders JR; Blanco RG; D'Souza G; Zhang Z; Chung CH; Kiess A; Gourin CG; Koch W; Richmon JD; Agrawal N; Eisele DW; Fakhry C
    Cancer; 2015 Jun; 121(12):1977-84. PubMed ID: 25782027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiotherapy in Metastatic Oropharyngeal Cancer.
    Nguy S; Oh C; Karp JM; Wu SP; Li Z; Persky MJ; Hu KS; Givi B; Tam MM
    Laryngoscope; 2021 Jun; 131(6):E1847-E1853. PubMed ID: 33141455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary Site Surgery in Distantly Metastatic Oropharyngeal Squamous Cell Carcinoma.
    Carey RM; Prasad A; Wei K; Brant JA; Brody RM; Leibowitz JM; Civantos FJ; Sweeny L
    Laryngoscope; 2024 May; 134(5):2243-2251. PubMed ID: 37947342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and Assessment of a Novel Composite Pathologic Risk Stratification for Surgically Resected Human Papillomavirus-Associated Oropharyngeal Cancer.
    Cramer JD; Dundar Y; Hotaling J; Raza SN; Lin HS
    JAMA Otolaryngol Head Neck Surg; 2019 Dec; 145(12):1105-1114. PubMed ID: 31042786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prognostic value of extranodal extension in human papillomavirus-associated oropharyngeal squamous cell carcinoma.
    An Y; Park HS; Kelly JR; Stahl JM; Yarbrough WG; Burtness BA; Contessa JN; Decker RH; Koshy M; Husain ZA
    Cancer; 2017 Jul; 123(14):2762-2772. PubMed ID: 28323338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The clinical value of oral robotic surgery in the treatment of oropharyngeal squamous cell carcinoma].
    Zhang X; Yang ZY; Yang AK; Zhang Q; Li QL; Chen SW; Chen JT; Song M
    Zhonghua Zhong Liu Za Zhi; 2022 Jun; 44(6):570-576. PubMed ID: 35754232
    [No Abstract]   [Full Text] [Related]  

  • 14. Extracapsular extension of neck nodes and absence of human papillomavirus 16-DNA are predictors of impaired survival in p16-positive oropharyngeal squamous cell carcinoma.
    Freitag J; Wald T; Kuhnt T; Gradistanac T; Kolb M; Dietz A; Wiegand S; Wichmann G
    Cancer; 2020 Jan; 126(9):1856-1872. PubMed ID: 32032442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overall survival, disease-free survival and quality of life in patients affected by HPV mediated p16+ oropharyngeal squamous cell carcinoma treated with upfront trans-oral robotic surgery vs radiotherapy or chemoradiotherapy.
    Fiacchini G; Picariello M; Dallan I; Tricò D; Casani AP; Amato F; Paiar F; Ursino S; Berrettini S; Bruschini L
    Eur Arch Otorhinolaryngol; 2024 Apr; 281(4):1913-1921. PubMed ID: 38180604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patterns of recurrence in head and neck squamous cell carcinoma to inform personalized surveillance protocols.
    Haring CT; Kana LA; Dermody SM; Brummel C; McHugh JB; Casper KA; Chinn SB; Malloy KM; Mierzwa M; Prince MEP; Rosko AJ; Shah J; Stucken CL; Shuman AG; Brenner JC; Spector ME; Worden FP; Swiecicki PL
    Cancer; 2023 Sep; 129(18):2817-2827. PubMed ID: 37162461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prognosis of HPV-associated metastatic pharyngeal patients by primary and distant site.
    Wang J; Tian Y; Huang H; Huang D; Liu Y; Tian Y; Zhu G; Zhang X; Ferris RL
    Oral Oncol; 2022 Feb; 125():105675. PubMed ID: 34968864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of the TNM-8 AJCC classification for HPV-positive oropharyngeal cancers in patients undergoing trans-oral robotic surgery.
    Olaleye O; Krishnan G; Beck J; Noor A; Bulsara V; Boase S; Solomon P; Krishnan S; Hodge JC; Foreman A
    J Robot Surg; 2023 Aug; 17(4):1463-1469. PubMed ID: 36780056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparing Outcomes for Patients with Human Papillomavirus (HPV) Type 16 versus Other High-Risk HPV Types in Oropharyngeal Squamous Cell Carcinoma.
    Shenker RF; May NH; Waltonen JD; Yang JP; O'Neill SS; Frizzell BA; Greven KM; Hughes RT
    Head Neck Pathol; 2021 Sep; 15(3):866-874. PubMed ID: 33616854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell-free human papillomavirus DNA kinetics after surgery for human papillomavirus-associated oropharyngeal cancer.
    O'Boyle CJ; Siravegna G; Varmeh S; Queenan N; Michel A; Pang KCS; Stein J; Thierauf JC; Sadow PM; Faquin WC; Wang W; Deschler DG; Emerick KS; Varvares MA; Park JC; Clark JR; Chan AW; Busse PM; Corcoran RB; Wirth LJ; Lin DT; Iafrate AJ; Richmon JD; Faden DL
    Cancer; 2022 Jun; 128(11):2193-2204. PubMed ID: 35139236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.